Orthopedic Biomaterials Product Market: Hip implant product segment is anticipated to carry major share of the market

The future of biomaterials is no longer limited to as abstract lab bench idea. It has grown to deliver life changing results to the human being. Biomaterials are in generally aimed for implanting in or on human body, thus used in treatment or replacement of human tissues or organs. A successful implant depends upon the type of biomaterial while an ideal biomaterial functionalizes with bioactive proteins and chemicals, is non-immunogenic, biocompatible, and biodegradable. Synthetic as well as natural biomaterials are being used since decades. Use of natural biomaterials have been traced back in history as far as 3000 BC where Egyptians are considered to be the first users. Egyptians used ivory and wood in tooth damage replacement, and coconut shells in skull damage. There are three generations of biomaterials in bone regenerations, of which first generation biomaterials include metals and ceramic products. Second generation biomaterial comprises naturally-derived and synthetic biodegradable polymers, calcium phosphates, calcium carbonate, calcium sulfate, and bioactive glasses. Regenerative biomaterials are third generation biomaterials that use bioactive and bioresorbable porous material as temporary 3-D structure that activate genes involved in stimulating regeneration of living tissue.

Read Report Overview - https://www.transparencymarketresearch.com/orthopedic-biomaterials-product-market.html

Regenerative medicine has emerged as a rapidly expanding field which has potential to serve organ shortage issues, organ replacement and regeneration. Regenerative medicine could also save money of public health bodies by reducing long term care of patients. Thus, regenerative biomaterial products are the current trend in the market. Rising awareness about stem cell therapy, technological advancements in the field, and a favorable government regulatory and reimbursement scenario are important factors fueling the market. Stem cell research has strengthened mainly by the support rendered by governments globally. The surge in federal funding has been observed after the bans were lifted from embryonic stem cells research in the U.S. in 2009. National Institute of Health (NIH) spent USD 1.47 billion and USD 1.391 billion in 2012 and 2014 respectively on research. Infusion of government funds is driving the market currently. However, the impact of this factor is expected to decline toward the end of the forecast period. This is due to the fact that the market would become self-sustaining and a resultant tapering of funds from government institutions will be observed.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39632

The global orthopedic biomaterials product market is classified on the basis of product, material type, end-user, and geography. In terms of product, the global orthopedic biomaterials product market is segmented into knee implant, hip implants, scaffolds, resorbable products, bone substitutes and others. Hip implant product segment is anticipated to carry major share of the market owing to rising geriatric population, increasing incidence of injuries related to accidents, sports, and adventure, and increased adoption of advanced hip products and procedures. The U.S. population is growing older as the baby boomer generation ages. The older population numbered 41.5 million in 2012, around 13.4% of the U.S. population. According to estimates from the Department of Health & Human Services, by 2030, geriatric population will reach about 72.1 million, which is more than twice the number from 2000.

Request for Analysis of COVID-19 Impact on Orthopedic Biomaterials Product Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=39632

Based on material, the global orthopedic biomaterials product market is segmented into metallic, ceramic, polymer, natural biomaterial, and regenerative biomaterials. Regenerative biomaterials segment is anticipated to reflect highest CAGR during the forecast period owing to favorable government criteria, technological advancements, and rising awareness about stem cell treatment. End-user segment of the global orthopedic biomaterials product market is divided into hospitals, specialized orthopedic clinics, and ambulatory surgery centers.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=39632

On the basis of region, the global orthopedic biomaterials product market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The rising penetration of bone-muscle distortion therapies in cases of accidents and growing demand in the young and active population for customized implant procedures are the factors driving adoption of knee implant reconstructive surgeries in the U.S. Many orthopedic reconstruction and trauma device manufacturers have experienced significant growth in the past several years in the U.S. This robust growth is due to a number of factors including demographics and the aging population, improved technologies, and increasing acceptance of implant devices by the younger generation.

Pre Book Orthopedic Biomaterials Product Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=39632&ltype=S

Some of the prominent players operating in the orthopedic biomaterials product market are Zimmer Biomet Holdings Inc., Johnson & Johnson, Globus Medical Inc., Zeus Industrial Products, Inc., Wright Medical Technology, Orthofix Holdings, Medtronic, and Arthrex Inc.

More Trending Reports by Transparency Market Research:

Urinalysis Market Urinalysis is a set of tests for detecting some common diseases such as kidney disorders, diabetes, liver problems, and urinary tract infections. The test consists of several microscopic, visual, and chemical examinations that identify cells, levels of creatinine, epithelial cells, and substances such as casts or crystals in the urine.

Weight loss products market A raft of weight management products have inundated the market these days. They range from food products to medical aids. They not just help people to tackle weight issues such as obesity and unnecessary weight gain, but also lower chances of weight-related health conditions such as high blood pressure, diabetes, cardiovascular diseases, etc.

Veterinary Drugs Market Developed countries have witnessed a high ownership in companion or livestock animals of several known and exotic varieties in the last few decades. Globally, livestock animals are domesticated for their economic value. Along with this, they are used in farming and agricultural activities as well.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

Back to news